Stella Diagnostics Inc.
OTC: SLDX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- David Seaburg
- Employees
- 2
- Headquarters
- Salt Lake City, United States
- IPO year
- 2021
- Market cap
- $1.0M
- Website
- https://www.stelladx.com
Loading SLDX…
Loading profile data…Frequently asked questions about SLDX
What does Stella Diagnostics Inc. (SLDX) do?
Stella Diagnostics Inc. is a molecular diagnostics firm primarily focused on advancing patient care strategies for individuals afflicted with severe esophageal disorders. The company's specialized clinical tests furnish physicians with crucial information regarding the molecular makeup of a patient's tissue, enabling them to ascertain if the dis...
Where does SLDX trade?
Stella Diagnostics Inc. (SLDX) trades on the Other OTC.
What sector is SLDX in?
Stella Diagnostics Inc. (SLDX) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Stella Diagnostics Inc.?
David Seaburg is the chief executive officer of Stella Diagnostics Inc. (SLDX).
Where is Stella Diagnostics Inc. headquartered?
Stella Diagnostics Inc. is headquartered in United States.
Does SLDX pay a dividend?
Stella Diagnostics Inc. (SLDX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SLDX go public?
Stella Diagnostics Inc. (SLDX) completed its initial public offering in 2021.